Oman granted observer status in ICH

Oman Sunday 22/November/2026 15:23 PM
By: ONA
Oman granted observer status in ICH

Muscat: Represented by the Drug Safety Centre at the Ministry of Health, the Sultanate of Oman has been granted observer status in the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

This milestone reflects the progress made by Oman’s pharmaceutical regulatory system and its growing participation in international health forums.

The ICH serves as an international platform that brings together regulatory authorities from different countries of the world for updates to harmonising technical requirements for pharmaceutical products. It is entrusted with establishing scientific guidelines and standards for upgrading the quality and safety of pharmaceuticals.

This status enables the Sultanate of Oman to benefit from international expertise and experience, stay informed about regulatory and scientific developments, build national capacity, and align its regulatory requirements with international guidelines—all of which contribute to enhancing the efficiency of the pharmaceutical regulatory system.

The Drug Safety Centre is all set implement the guidelines of the ICH, support local pharmaceutical industry and facilitate the exchange of expertise with member states and other parties concerned.

This achievement is part of ongoing efforts made by the Ministry of Health to develop the pharmaceutical sector and improve the efficiency of its regulatory framework in line with the goals of Oman Vision 2040, which seeks to establish a more efficient and sustainable healthcare system.